Inventor · disambiguated record
Antonius Nicolaas Maria Schumacher
Also filed as: SCHUMACHER ANTONIUS · SCHUMACHER ANTONIUS NICOLAAS M · SCHUMACHER ANTONIUS NICOLAAS MARIA
5 granted patents·12 pending applications·10 citations·filing 2002–2023
70Inventor score
Files withSTICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS4NEOGENE THERAPEUTICS B V2OVAA HUIB2UNIV MUENCHEN TECH2AIMM THERAPEUTICS BV1
Top patents by PatentIndex Score
17 records- 0180US9079941B2Means and methods for breaking noncovalent binding interactions between moleculesOVAA HUIB·Filed 2006·Granted Jul 14, 2015·7 cites·11 claims
- 0267US2024036053A1T cell receptors and peptides derived by mutations for the treatment of cancerUNIV MUENCHEN TECH·Filed 2023·Application pending·0 cites
- 0365US2025281610A1P2ry2 activity modulatorsDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2023·Application pending·0 cites
- 0454US9151757B2Detecting antigen responsive cells in a sampleREKER-HADRUP SINE·Filed 2008·Granted Oct 6, 2015·3 cites·17 claims
- 0553US2022087981A1Treating pathological conditions by direct and indirect targeting of sirpa-cd47 interactionSTICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS·Filed 2021·Application pending·0 cites
- 0652US2025206789A1Zinc finger degron sequencesSTICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS·Filed 2023·Application pending·0 cites
- 0751US11614449B2T cell receptors and peptides derived by mutations for the treatment of cancerUNIV MUENCHEN TECH·Filed 2016·Granted Mar 28, 2023·0 cites·18 claims
- 0845US2021293820A1Methods of activating dysfunctional immune cells and treatment of cancerYEDA RES & DEV·Filed 2021·Application pending·0 cites
- 0944US9850287B2Means and methods for breaking noncovalent binding interactions between moleculesHET NEDERLANDS KANKER INST·Filed 2015·Granted Dec 26, 2017·0 cites·8 claims
- 1043US2019365717A1Treating pathological conditions by direct and indirect targeting of sirpa-cd47 interactionSTICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS·Filed 2019·Application pending·0 cites
- 1141US2023151373A1Chimeric polypeptide for regulating immune cellsSTICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS·Filed 2020·Application pending·0 cites
- 1240US2014004137A1Immune restricted peptides with increased efficacyOVAA HUIB·Filed 2011·Application pending·0 cites
- 1339US2003082719A1T cell receptor librariesFiled 2002·Application pending·0 cites
- 1436US2022228164A1Engineered antigen presenting cellsNEOGENE THERAPEUTICS B V·Filed 2022·Application pending·0 cites
- 1534US10690658B2Means and methods for determining T cell recognitionAIMM THERAPEUTICS BV·Filed 2015·Granted Jun 23, 2020·0 cites·30 claims
- 1631US2021040558A1Method to isolate tcr genesNEOGENE THERAPEUTICS B V·Filed 2020·Application pending·0 cites
- 1728US2017354681A1T cell-based immunotherapeuticsBCRT HOLDING BV·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Antonius Nicolaas Maria Schumacher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →